Cilostazol to prevent repeat stroke in Africa
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests if the drug cilostazol can prevent another stroke in people who have already had one. It is designed for patients in Africa and compares adding cilostazol to standard aspirin or clopidogrel therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 30 years old.
- You had a stroke or high-risk mini-stroke within the last 6 months, confirmed by a brain scan.
- You are only taking one blood thinner medicine (aspirin or clopidogrel) — not both.
- You do not have severe heart failure, active bleeding, or a recent brain bleed.
- You are willing to attend 7 study visits over time.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two medications—cilostazol and aspirin—to see which is better at preventing another stroke in people who have had a recent clot-caused stroke and also have tiny spots of bleeding in the brain (microbleeds). It aims to find a safer and more effective treatment for this specific group.
This trial tests whether placing a stent in a severely narrowed brain artery, along with aggressive medication, can prevent another stroke better than medication alone. It is for people who had a mild stroke within the last 30 days due to a 70-99% blockage in a major brain artery.
This trial tests whether cilostazol, a medication that helps keep blood flowing, can prevent another stroke and slow down disease progression in people who have had a recent stroke caused by small vessel disease. It aims to stop the brain damage from getting worse.
This trial tests a drug called cilostazol to see if it can help prevent a second stroke or mini-stroke. You may be a candidate if you have had a stroke or mini-stroke in the past 6 months and are already taking one blood thinner (aspirin or clopidogrel), but not both.
This trial tests whether adding cilostazol or clopidogrel to aspirin is safe and effective for people who recently had a mild stroke or a transient ischemic attack (TIA) caused by a large artery blockage. It aims to prevent another stroke during the first 90 days.
This trial is testing whether combining aspirin with either cilostazol or clopidogrel is more effective at preventing another stroke after a minor stroke or TIA. It is for people who had their first mild stroke or TIA and started a blood thinner within 24 hours.
Hear when a new Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.